These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1198414)

  • 1. Proceedings: Characterisitics of platelet protransglutaminase (factor XIII)-binding activity in human plasma.
    Bannerjee D; Mosesson MW
    Thromb Diath Haemorrh; 1975 Nov; 34(2):549. PubMed ID: 1198414
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet factor XIII becomes active without the release of activation peptide during platelet activation.
    Muszbek L; Polgár J; Boda Z
    Thromb Haemost; 1993 Mar; 69(3):282-5. PubMed ID: 8097064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Packaging zinc, fibrinogen, and factor XIII in platelet alpha-granules.
    Marx G; Korner G; Mou X; Gorodetsky R
    J Cell Physiol; 1993 Sep; 156(3):437-42. PubMed ID: 8360253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of platelet protransglutaminase (Factor XIII) - binding activity in human plasma.
    Bannerjee D; Mosesson MW
    Thromb Res; 1975 Aug; 7(2):323-7. PubMed ID: 1162651
    [No Abstract]   [Full Text] [Related]  

  • 5. Factor XIII in human plasma and platelets.
    McDonagh J; McDonagh RP; Delâge JM; Wagner RH
    J Clin Invest; 1969 May; 48(5):940-6. PubMed ID: 5780202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytofluorometric identification of plasmin-sensitive factor XIIIa binding to platelets.
    Kreager JA; Devine DV; Greenberg CS
    Thromb Haemost; 1988 Aug; 60(1):88-93. PubMed ID: 2903577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and platelet fibrin-stabilizing factor activity in rats intoxicated with phenylmercuric acetate.
    Michalska M; Wierzbicki R
    Pol J Pharmacol Pharm; 1984; 36(6):611-5. PubMed ID: 6535154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of major surgical procedures on plasma and platelet levels of Factor XIII.
    Letheby BA; Davis RB; Larsen AE
    Thromb Diath Haemorrh; 1974 Mar; 31(1):20-9. PubMed ID: 4836136
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrin-fibrin and alpha 2-antiplasmin-fibrin cross-linking by platelet factor XIII increases the resistance of platelet clots to fibrinolysis.
    Reed GL; Matsueda GR; Haber E
    Trans Assoc Am Physicians; 1991; 104():21-8. PubMed ID: 1845147
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracellular factor XIII crosslinks platelet cytoskeletal elements upon platelet activation.
    Serrano K; Devine DV
    Thromb Haemost; 2002 Aug; 88(2):315-20. PubMed ID: 12195706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retention of platelet fibrin stabilizing factor during the platelet release reaction and clot retraction.
    Joist JH; Niewiarowski S
    Thromb Diath Haemorrh; 1973 Jun; 29(3):679-83. PubMed ID: 4271547
    [No Abstract]   [Full Text] [Related]  

  • 12. [Proceedings: Determination of Factor XIII (fibrin-stabilizing factor) in plasma and blood platelets].
    Ballerini G; Franceschini F; Guerra S; Meduri P; Scagliarini F
    Quad Sclavo Diagn; 1973 Mar; 9(1):497-581. PubMed ID: 4210088
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the fibrin stabilizing factor in human platelets: its content in normal thrombocytes and in platelets with functional defects.
    Wenzel E; Oppolzer R
    Acta Univ Carol Med Monogr; 1972; 53():173-8. PubMed ID: 4133928
    [No Abstract]   [Full Text] [Related]  

  • 14. The difference between platelet and plasma FXIII used to study the mechanism of platelet microvesicle formation.
    Holme PA; Brosstad F; Solum NO
    Thromb Haemost; 1993 Oct; 70(4):681-6. PubMed ID: 8115996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Change in factor XIII activity in plasma during thrombocyte aggregation].
    Pastorova VE; Umarova BA
    Biull Eksp Biol Med; 1975 Jul; 80(7):14-7. PubMed ID: 1227639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains.
    Siebenlist KR; Meh DA; Mosesson MW
    Biochemistry; 1996 Aug; 35(32):10448-53. PubMed ID: 8756701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII).
    Polgár J; Hidasi V; Muszbek L
    Biochem J; 1990 Apr; 267(2):557-60. PubMed ID: 1970724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of platelet agglutinating protein p37 from the plasma of a patient with thrombotic thrombocytopenic purpura to human platelets.
    Lian EC; Siddiqui FA
    Thromb Haemost; 1991 Jan; 65(1):96-101. PubMed ID: 2024244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface.
    Dale GL; Friese P; Batar P; Hamilton SF; Reed GL; Jackson KW; Clemetson KJ; Alberio L
    Nature; 2002 Jan; 415(6868):175-9. PubMed ID: 11805836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.